FDA approves first drug to treat lymphoma in dogs
The FDA has approved a medication specifically designed to treat lymphoma in dogs, potentially helping extend the lives of thousands of pets.
Natural killer cells fight cancer without collateral damage
Researchers at McMaster have developed a form of immunotherapy capable of working on solid tumors in the lab.
Sky-mapping system can predict whether cancer treatment will work
Johns Hopkins researchers are using image analysis developed for astronomy to study cancer immunotherapy.
Pharma giant GSK embraces digital twins for vaccine development
Pharma leviathan GlaxoSmithKline is rolling out digital twins to help create “the vaccine factory of the future.”
CRISPR therapy cures first genetic disorder inside the body
For the first time, researchers appear to have effectively cured a genetic disorder by directly injecting a CRISPR therapy into patients’ bloodstreams.
Diagnosing infections without the lab — or wait
Researchers have developed a device that can test for infections in under an hour, no lab needed.
A new superbug strategy
Researchers at the University of Geneva have a new idea on how to stop superbugs: don’t kill them.
There may be a way to reverse acetaminophen damage in the liver
New research out of Singapore suggests that a protein thought to help acetaminophen toxicity may do the opposite.
Urine test for brain cancer detects tumors of any size
A new urine test for brain cancer analyzed microRNAs to correctly identify 100% of patients with brain tumors, regardless of their tumor’s size.